BlueCrest Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

BlueCrest Capital Management’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,433	Closed	-$44K	–	1107
2019 Q1	$44K	Buy	+1,433	New	+$48K	﹤0.01%	1132
2018 Q4	–	Sell	-1,077	Closed	-$81K	–	1495
2018 Q3	$81K	Sell	1,077 -761	-41%	-$51.5K	﹤0.01%	1408
2018 Q2	$104K	Sell	1,838 -5,812	-76%	-$212K	﹤0.01%	1388
2018 Q1	$169K	Buy	+7,650	New	+$175K	0.01%	1304

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlueCrest Capital Management's ASXC Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q2 2019, closing a stake of 1,433 shares — an estimated $44K sold.

BlueCrest Capital Management first reported a position in ASXC in Q1 2018 and held it in 4 quarters. The position peaked at $169K in Q1 2018. 141 funds tracked by Wall St. Rank hold ASXC as of Q2 2019.

BlueCrest Capital Management reported no remaining Asensus Surgical, Inc. position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 1,433 Asensus Surgical, Inc. shares in Q2 2019, an estimated $44K.
BlueCrest Capital Management first reported a position in Asensus Surgical, Inc. in Q1 2018 and held it in 4 quarters.
BlueCrest Capital Management's Asensus Surgical, Inc. position peaked at $169K in Q1 2018.
141 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.